×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SION – sionna therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SION
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
3/2
01:00 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
3/2
07:13 am
sion
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/2
07:00 am
sion
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2/27
11:30 am
sion
Assessing Sionna Therapeutics (SION) Valuation As Premium P/B Meets Cooling Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Sionna Therapeutics (SION) Valuation As Premium P/B Meets Cooling Share Price Momentum [Yahoo! Finance]
2/26
06:28 am
sion
Sionna Therapeutics (SION) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
Sionna Therapeutics (SION) was upgraded by Lifesci Capital to "strong-buy".
2/24
08:00 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $63.00 price target on the stock.
Low
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $63.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/5
04:29 pm
sion
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
Neutral
Report
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
3/2
08:19 am
sion
Form S-3ASR Sionna Therapeutics,
Medium
Report
Form S-3ASR Sionna Therapeutics,
3/2
07:20 am
sion
Form 10-K Sionna Therapeutics, For: Dec 31
Medium
Report
Form 10-K Sionna Therapeutics, For: Dec 31
3/2
07:09 am
sion
Form 8-K Sionna Therapeutics, For: Mar 02
Medium
Report
Form 8-K Sionna Therapeutics, For: Mar 02
2/4
07:44 pm
sion
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: Thompson Peter A.
High
Report
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: Thompson Peter A.
2/4
07:39 pm
sion
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: ORBIMED ADVISORS LLC
High
Report
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: ORBIMED ADVISORS LLC
1/26
05:25 pm
sion
Form 4 Sionna Therapeutics, For: Jan 22 Filed by: WINKELRIED JON
Low
Report
Form 4 Sionna Therapeutics, For: Jan 22 Filed by: WINKELRIED JON
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: